Geraldine Henwood Baudax Bio, Inc. (BXRX) insider trading activity

Geraldine Henwood is President and CEO of Baudax Bio, Inc.. Currently has a direct ownership of 2,427 shares of BXRX, which is worth approximately $24. The most recent transaction as insider was on Dec 15, 2022, when has been sold 1,200 shares (Common Stock) at a price of $2.55 per share, resulting in proceeds of $3,060. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.43K

0% 3M change

0% 12M change

Total Value Held $24

GERALDINE HENWOOD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2022	BUY Open market or private purchase	$3,060 $2.55 p/Share	1,200 Added 33.09%	2,427 Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	39,473 Added 44.57%	49,093 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$5,777 $0.31 p/Share	18,636 Reduced 5.24%	336,716 Common Stock
Dec 05 2021	SELL Payment of exercise price or tax liability	$3,204 $0.35 p/Share	9,155 Reduced 2.51%	355,352 Common Stock
Sep 22 2021	BUY Open market or private purchase	$4,838 $0.59 p/Share	8,200 Added 2.2%	364,507 Common Stock
May 07 2021	BUY Open market or private purchase	$4,980 $0.83 p/Share	6,000 Added 1.66%	356,307 Common Stock
Jan 20 2021	BUY Grant, award, or other acquisition	-	65,435 Added 15.74%	350,307 Common Stock
Dec 05 2020	SELL Payment of exercise price or tax liability	$94,637 $1.14 p/Share	83,015 Reduced 22.57%	284,872 Common Stock

Also insider at

REPH

Societal CDMO, Inc. Healthcare

Director